Cargando…
Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
An association between high levels of serum urate and cardiovascular disease has been proposed for many decades. However, it was only recently that compelling basic science data, small clinical trials, and epidemiological studies have provided support to the idea of a true causal effect. In this rev...
Autores principales: | Gaffo, Angelo L, Edwards, N Lawrence, Saag, Kenneth G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745789/ https://www.ncbi.nlm.nih.gov/pubmed/19725932 http://dx.doi.org/10.1186/ar2761 |
Ejemplares similares
-
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010) -
Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021) -
Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine
por: Gaffo, Angelo L, et al.
Publicado: (2008) -
Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009) -
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review
por: Pisaniello, Huai Leng, et al.
Publicado: (2021)